Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAvantor Inc

Avantor Inc

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
15.615 USD -0.12 ( 0.73%)
Last update at 2026-11-12T15:46:00Z
VOLUME
552680
Market Cap
5817.94M

Momentum Score

…

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
15.25
Low
15.99
High
52 Week Price Range
7.26
Low
15.93
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Avantor supplies materials, consumables and services to life sciences, advanced technologies and applied materials customers worldwide, operating distribution, manufacturing and laboratory-support channels. Long-term growth may be driven by rising biopharma R&D, expanding lab capacity, recurring consumables demand and international expansion. Investors may find the company attractive for its diversified customer base, broad product portfolio and global distribution scale that could support consistent revenue streams.
Key risks include elevated leverage from prior acquisitions, execution and integration challenges, competitive pricing pressure and supply‑chain or regulatory disruptions that could compress margins and cash flow.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
15.73
Dividend Yield
-
Revenue TTM
6552.20M
Revenue Per Share
9.63
Gross Profit TTM
2139.40M
Debt / Equity
0.71
ROE
-9.20%
Net Debt
3580.90M
ROCE
-2.61%
Diluted EPS TTM
-0.78

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -441.30M 853.90M 410.50M 851.10M 753.00M
Net income -530.20M 711.50M 321.10M 686.50M 572.60M
Selling general administrative 1595.50M 1641.10M 1506.60M 1472.60M 1530.50M
Gross profit 2139.40M 2279.30M 2363.80M 2602.80M 2502.70M
Reconciled depreciation 410.20M 405.50M 402.30M 405.50M 379.20M
Ebit -271.50M 1072.70M 695.30M 1130.20M 972.20M
Ebitda 138.70M 1478.20M 1097.60M 1534.90M 1362.00M
Depreciation and amortization 410.20M 405.50M 402.30M 404.70M 389.80M
Non operating income net other - - - -13.30M -1.80M
Operating income -246.20M 1084.80M 696.40M 1130.20M 972.20M
Other operating expenses 6798.40M 5698.80M 6270.80M 6382.20M 6413.90M
Interest expense 169.80M 218.80M 284.80M 265.80M 217.40M
Tax provision 88.90M 142.40M 89.40M 164.60M 180.40M
Net interest income -169.80M -218.80M -284.80M -265.80M -217.40M
Income tax expense 88.90M 142.40M 89.40M 164.60M 180.40M
Total revenue 6552.20M 6783.60M 6967.20M 7512.40M 7386.10M
Total operating expenses 2385.60M 1194.50M 1667.40M 1472.60M 1530.50M
Cost of revenue 4412.80M 4504.30M 4603.40M 4909.60M 4883.40M
Total other income expense net -195.10M -230.90M -285.90M -279.10M -219.20M
Net income from continuing ops -530.20M 711.50M 321.10M 686.50M 572.60M
Net income applicable to common shares - - - 662.30M 508.00M
Preferred stock and other adjustments - - - 24.20M 64.60M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 11794.70M 12114.50M 12972.70M 13464.30M 13897.20M
Intangible assets 3193.80M 3359.90M 3775.30M 4133.30M 5140.30M
Other current assets 193.00M 118.70M 143.70M 153.10M 81.40M
Total liab 6229.70M 6157.80M 7720.10M 8608.90M 9700.20M
Total stockholder equity 5565.00M 5956.70M 5252.60M 4855.40M 4197.00M
Deferred long term liab - - - 731.40M 913.00M
Other current liab 606.40M 523.60M 594.50M -195.00M 401.00M
Common stock 3984.80M 3937.70M 3830.10M 3785.30M 2752.60M
Capital stock 3984.80M 3937.70M 3830.10M 3785.30M 3756.30M
Retained earnings 1672.80M 2203.00M 1491.50M 1170.40M 483.90M
Other liab - - - 940.20M 1271.40M
Good will 4986.90M 5539.20M 5716.70M 5652.60M 5341.10M
Other assets - 0.30M - 174.80M 233.10M
Cash 365.40M 261.90M 262.90M 372.90M 301.70M
Total current liabilities 1378.90M 2007.50M 1480.30M 1658.80M 1450.80M
Current deferred revenue - - 183.30M 731.40M 249.50M
Net debt 3580.90M 3793.90M 5273.70M 5914.60M 6721.50M
Short term debt 30.80M 821.10M 259.90M 364.20M 45.20M
Short long term debt 30.80M 821.10M 259.90M 364.20M 45.20M
Short long term debt total 3946.30M 4055.80M 5536.60M 6287.50M 7023.20M
Other stockholder equity -75.70M 2203.00M -0.00M -100.30M 1003.70M
Property plant equipment - - - 727.00M 705.50M
Total current assets 2451.20M 2146.60M 2384.90M 2657.90M 2477.20M
Net tangible assets - - - -4930.50M -7288.10M
Short term investments - - 16.60M - -
Net receivables 1074.60M 1034.50M 1150.20M 1218.40M 1222.10M
Long term debt 3915.50M 3234.70M 5276.70M 5923.30M 6978.00M
Inventory 818.20M 731.50M 828.10M 913.50M 872.00M
Accounts payable 741.70M 662.80M 625.90M 758.20M 755.10M
Accumulated other comprehensive income -16.90M -184.00M -69.00M -100.30M -43.20M
Common stock total equity - - - 3785.30M 2752.60M
Preferred stock total equity - - - - 1003.70M
Retained earnings total equity - - - 1170.40M 483.90M
Non currrent assets other 396.00M 360.40M 187.50M 293.50M 233.10M
Non current assets total 9343.50M 9967.60M 10587.80M 10806.40M 11420.00M
Long term debt total - - - 5923.30M 6978.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 438.90M -126.80M -109.60M -4121.70M
Change to liabilities - - - 15.70M 64.90M
Total cashflows from investing activities -130.50M 438.90M -143.70M -109.60M -4121.70M
Net borrowings -318.70M -1341.80M -846.00M -620.40M 2300.70M
Total cash from financing activities -409.40M -1281.20M -843.70M -648.70M 3219.20M
Change to operating activities - - - -179.20M 62.20M
Net income -530.20M 711.50M 321.10M 686.50M 572.60M
Change in cash 103.60M -23.00M -109.20M 69.80M 37.90M
Begin period cash flow 264.70M 287.70M 396.90M 327.10M 289.20M
End period cash flow 368.30M 264.70M 287.70M 396.90M 327.10M
Total cash from operating activities 623.80M 840.80M 870.00M 843.60M 953.60M
Issuance of capital stock - - 0.00M 0.00M 967.00M
Depreciation 410.20M 405.50M 402.30M 405.50M 379.20M
Other cashflows from investing activities -1.70M 587.70M 2.70M -18.70M 3.50M
Dividends paid - 0.00M 18.30M -32.40M -64.60M
Change to inventory -109.40M -18.50M 30.30M -112.50M -129.80M
Change to account receivables 13.60M 45.90M 77.00M -45.20M -111.80M
Sale purchase of stock -80.70M -8.60M -13.70M -13.20M -25.80M
Other cashflows from financing activities -15.10M 69.20M 16.00M 343.90M 2876.50M
Change to netincome - - - -7.80M 100.00M
Capital expenditures 128.80M 148.80M 146.40M 133.40M 111.10M
Change receivables - - - -45.20M -111.80M
Cash flows other operating - - - -114.30M 101.80M
Cash and cash equivalents changes - - - 85.30M 51.10M
Change in working capital -198.90M 47.70M 16.60M -321.30M -114.50M
Stock based compensation 46.40M 46.80M 40.50M 45.80M 50.70M
Other non cash items 888.60M -323.80M 261.90M 96.20M 83.30M
Free cash flow 495.00M 692.00M 723.60M 710.20M 842.50M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AVTR
Avantor Inc		 -0.12
0.73%		 15.62 - 8.30 0.89 1.03 1.42 67.25
ISRG
Intuitive Surgical Inc		 -8.88
1.97%		 440.65 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -2.56
1.26%		 200.18 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -1.98
1.94%		 99.87 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 0.83
0.39%		 215.35 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Avantor Inc

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Radnor Corporate Center, Radnor, PA, United States, 19087

610 386 1700

https://www.avantorsciences.com

13500

Name Title Year Born
Mr. Michael Stubblefield Pres, CEO & Director 1973
Mr. Thomas A. Szlosek Exec. VP & CFO 1964
Dr. Gerard Brophy Ph.D. Exec. VP of Biopharma Production 1966
Mr. Frederic Vanderhaegen Exec. VP of Europe 1967
Ms. Sheri Lewis Exec. VP of Global Supply Chain 1966
Mr. Steven W. Eck Sr. VP, Corp. Controller & Chief Accounting Officer 1977
Mr. Michael Wondrasch Exec. VP & Chief Information Officer 1969
Mr. Tommy J. Thomas CPA VP of Investor Relations NA
Mr. Justin M. Miller Esq. Exec. VP, Gen. Counsel & Sec. 1967
Ms. Allison K. Hosak Sr. VP of Global Communications & Brand NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 106.39
+7.88%
GRZ
CAD 4.80
+5.26%
CTC
CAD 226.00
+4.63%
CAE
CAD 40.63
+4.21%
FEC
CAD 7.26
+3.57%
FSZ
CAD 2.40
-15.79%
TF
CAD 4.56
-11.28%
ITR
CAD 2.71
-9.67%
LAR
CAD 5.23
-7.43%
BZ
CAD 4.00
-7.41%

Equity Sectors*

  • Basic Materials

    -2.89%

  • Communication Services

    +0.25%

  • Consumer Cyclical

    +0.37%

  • Consumer Defensive

    -0.02%

  • Energy

    -0.30%

  • Financial Services

    -1.06%

  • Healthcare

    -0.73%

  • Industrials

    -0.49%

  • Real Estate

    +0.22%

  • Technology

    -1.52%

  • Utilities

    +0.08%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…